Latest Manufacturing News

Warriedar Resources has confirmed significant high-grade antimony mineralisation at its Azure Coast deposit near the Ricciardo gold project, unveiling new potential in the Golden Range belt. The company plans targeted drilling later this year to expand on these promising results.

Neurizon Therapeutics has inked a pivotal global licensing deal with Elanco Animal Health, unlocking critical intellectual property and data to accelerate the development and commercialisation of its lead drug candidate NUZ-001 for neurodegenerative diseases including ALS.

Civmec Limited has completed its acquisition of Luerssen Australia, reinforcing its position in Australia's naval shipbuilding industry and supporting key defense programs.

Washington H. Soul Pattinson and Brickworks have announced a conditional placement of 14 million Topco shares and a concurrent repurchase of up to $450 million in convertible notes, setting the stage for their upcoming merger.

Washington H. Soul Pattinson and Brickworks announce a conditional $14 million Topco share placement and a concurrent repurchase of up to $450 million in convertible notes, key steps in their proposed merger.

Mesoblast has secured FDA agreement on key requirements for its Biologics License Application for Revascor, targeting ischemic heart failure patients with reduced ejection fraction. The company aims for accelerated approval by year-end 2025.

First Graphene Limited has secured two significant orders totaling approximately A$165,000 for its PureGRAPH graphene products, signaling growing market acceptance and supporting its FY25-26 sales outlook.

Metro Performance Glass has locked in a minimum $15 million capital raise and a new three-year loan facility, positioning itself for growth with Amari Metals Australia set to become the majority shareholder.

Titomic’s Netherlands division has secured €800,000 in funding from the Dutch 3D Print Kompas program to advance its Cold Spray Additive Manufacturing technology, aiming to expand R&D and industrial applications across Europe.

Metal Powder Works has doubled its production capacity and launched continuous 24/7 automated manufacturing at its Pittsburgh facility, marking a significant leap in operational efficiency and cost competitiveness.

Brickworks Limited reports a mixed second half of FY25 with strong property gains offset by a significant impairment in its North American operations, while its planned merger with Soul Patts remains on track.

LTR Pharma has successfully completed the extractables study for its intranasal erectile dysfunction spray SPONTAN, confirming safety compliance and initiating the next phase of leachables testing to support FDA approval.